Kynam Capital Management, LP Seres Therapeutics, Inc. Transaction History

Kynam Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.95 - $6.09 $38,357 - $47,191	-7,749 Reduced 1.0%	768,913 $4.36 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $19,555 - $34,770	3,842 Added 0.5%	776,662 $4.35 Million
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $1.8 Million - $3.7 Million	514,173 Added 198.79%	772,820 $4.96 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $88,549 - $249,905	-32,796 Reduced 11.25%	258,647 $887,000
Q1 2022 May 13, 2022	SELL	$6.3 - $8.84 $84,785 - $118,968	-13,458 Reduced 4.41%	291,443 $2.08 Million

Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $1.84 Million - $3.49 Million	304,901 New	304,901 $2.54 Million

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Kynam Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Kynam Capital Management, LP with notifications on news.